(March 29 21:00) Forbes.com
Transforming mRNA therapeutics into clinical realities requires easy and fast access to synthetic DNA in the design-build-test-learn iteration cycle. This is one of the rate-limiting steps that must be overcome to speed mRNA therapy innovations.
You can find the original article
here